OPTC Antibody, HRP conjugated

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship your order within 1-3 business days of receipt. Delivery times may vary depending on the purchase method and location. For specific delivery times, please consult your local distributors.
Synonyms
Oculoglycan antibody; OPT antibody; OPT_HUMAN antibody; OPTC antibody; Opticin antibody
Target Names
OPTC
Uniprot No.

Target Background

Function
Opticin exhibits anti-angiogenic properties in the vitreous humor of the eye, effectively suppressing neovascularization. It binds to collagen fibrils and may play a role in collagen fiber organization by regulating other members of the small leucine-rich repeat proteoglycan superfamily.
Gene References Into Functions
  1. Opticin binds to collagen, competitively inhibiting endothelial cell interactions with collagen via alpha(1)beta(1) and alpha(2)beta(1) integrins. This inhibition prevents the strong adhesion necessary for proangiogenic signaling through these integrins. PMID: 22669977
  2. VEGF and hypoxia can decrease opticin protein levels in the human retinal pigment epithelium secretome, and opticin may serve as an enzymatic substrate for MMP-2. PMID: 22534113
  3. Opticin's localization in the human eye and genetic screen of opticin. PMID: 12019215
  4. OPTC is a candidate gene for primary open-angle glaucoma. PMID: 17359525
  5. OPTC and EPYC are unlikely to play a significant role in high myopia. PMID: 19844586

Show More

Hide All

Database Links

HGNC: 8158

OMIM: 605127

KEGG: hsa:26254

STRING: 9606.ENSP00000356191

UniGene: Hs.632468

Protein Families
Small leucine-rich proteoglycan (SLRP) family, SLRP class III subfamily
Subcellular Location
Secreted, extracellular space, extracellular matrix.
Tissue Specificity
Expressed in cartilage and synovial membranes (at protein level). Expressed in the retina, iris, ligament, skin and fetal liver (at protein level). Expressed in the retinal pigment epithelium (at protein level). Expressed in synovial fibroblasts and subch

Q&A

What is an OPTC Antibody, HRP conjugated, and how does it function in immunoassays?

OPTC (Opticin) Antibody, HRP conjugated, is a detection tool consisting of an antibody targeting the Opticin protein chemically linked to horseradish peroxidase enzyme. HRP conjugation works through chemical modification of carbohydrate moieties on the HRP molecule, typically using sodium meta-periodate to generate aldehyde groups. These aldehydes form covalent bonds with amino groups on antibodies through Schiff's base formation, which is then stabilized by reduction with sodium cyanoborohydride .

In immunoassays, the antibody component binds specifically to OPTC antigens while the conjugated HRP enzyme catalyzes the oxidation of substrates (like TMB or DAB) in the presence of hydrogen peroxide, producing a detectable color change or chemiluminescent signal. This conjugation strategy preserves both the antigen-binding capacity of the antibody and the enzymatic activity of HRP, creating a versatile detection tool .

What are the optimal dilution ratios for OPTC Antibody, HRP conjugated in various applications?

The optimal dilution depends on the specific application, conjugation method, and target abundance. Based on research data:

ApplicationRecommended Starting DilutionOptimization RangeNotes
Western Blot1:10001:500-1:5000For standard protein detection
Direct ELISA1:10001:500-1:5000Enhanced sensitivity with optimized conjugates
Immunohistochemistry1:1001:50-1:500Paraffin-embedded tissues
Immunocytochemistry1:2001:100-1:1000Dependent on cell type and fixation method

Importantly, laboratory validation is essential as enhanced conjugation methods can dramatically improve sensitivity. Research has demonstrated that optimized HRP conjugation protocols can enable dilutions as high as 1:5000 while maintaining signal detection, compared to classical methods that may only work effectively at 1:25 dilutions (p < 0.001) .

How should OPTC Antibody, HRP conjugated be stored to maintain optimal activity?

Proper storage is critical for maintaining the functional integrity of HRP-conjugated antibodies:

  • Short-term storage (up to 6 months): 4°C with appropriate stabilizers added

  • Long-term storage: -20°C in single-use aliquots to prevent freeze-thaw cycles

  • Avoid repeated freeze-thaw cycles which can reduce both antibody binding capacity and HRP enzymatic activity

  • Store in darkness as HRP is light-sensitive

  • Consider adding stabilizers such as 50% glycerol, 1% BSA, or commercial antibody stabilizers

Research indicates that lyophilized activated HRP can be maintained at 4°C for extended periods without significant loss of activity, providing an advantage for laboratory stock management .

What substrates are most compatible with OPTC Antibody, HRP conjugated for different detection methods?

SubstrateDetection MethodSensitivityAdvantagesLimitations
TMB (3,3',5,5'-tetramethylbenzidine)ColorimetricModerate-HighStable, low background, suitable for quantitative analysisTime-dependent color development
DAB (3,3'-diaminobenzidine)Colorimetric (IHC)ModerateProduces brown precipitate, permanent recordLess sensitive than chemiluminescent methods
ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid))ColorimetricModerateWater-soluble, environmentally friendlyLess stable signal
Luminol-based reagentsChemiluminescenceVery HighExtremely sensitive, wide dynamic rangeRequires specialized detection equipment
Tyramide Signal AmplificationFluorescence/AmplificationExtremely HighCan detect very low abundance targetsMore complex protocol, potential background issues

Research confirms that enhanced HRP-conjugated antibodies can detect antigens at concentrations as low as 1.5 ng when optimized substrate systems are employed .

How does the lyophilization process enhance HRP-antibody conjugation efficiency?

Lyophilization significantly improves HRP-antibody conjugation through several mechanistic advantages:

  • Concentration effect: Lyophilization of activated HRP reduces reaction volume without changing reactant amounts, effectively increasing molecular collision frequency according to collision theory .

  • Preservation of active aldehyde groups: The freeze-drying process stabilizes the reactive aldehyde groups generated during periodate oxidation, preventing their degradation before reaction with antibodies .

  • Reaction stoichiometry improvement: Research demonstrates that the freeze-dried activated HRP enables a more favorable molar ratio interaction with antibodies, allowing more HRP molecules to conjugate per antibody molecule, creating poly-HRP structures .

  • Enhanced stability: Lyophilized activated HRP maintains its reactive potential during storage at 4°C for extended periods, providing practical advantages for laboratory workflows .

Experimental data shows that conjugates prepared using lyophilization-enhanced methods exhibited significant performance improvements in ELISA, working effectively at dilutions of 1:5000 compared to classical methods that required much higher concentrations (1:25 dilution) to achieve comparable signals (p < 0.001) .

What are the critical factors affecting sensitivity in immunoassays using OPTC Antibody, HRP conjugated?

Multiple factors influence assay sensitivity when using HRP-conjugated antibodies:

FactorImpact on SensitivityOptimization Strategy
HRP:Antibody ratioHigher ratios increase signal but may compromise antibody bindingExperimentally determine optimal ratio (typically 2-4 HRP per antibody)
Conjugation methodPeriodate method preserves antibody function better than glutaraldehydeConsider enhanced methods with lyophilization step
Buffer compositionCan affect both enzyme activity and antibody bindingOptimize pH, ionic strength, and presence of stabilizers
Substrate selectionDifferent substrates have different sensitivity thresholdsMatch substrate to required detection sensitivity
Incubation conditionsTemperature and time affect reaction kineticsOptimize for specific antibody-antigen interaction
Sample complexityComplex samples increase background and non-specific bindingImplement appropriate blocking and washing procedures

Research validates that the modified periodate method with lyophilization can detect antigens at concentrations as low as 1.5 ng, representing a significant improvement over classical conjugation approaches .

How can researchers troubleshoot non-specific binding issues when using OPTC Antibody, HRP conjugated?

Non-specific binding represents a common challenge with HRP-conjugated antibodies. A systematic troubleshooting approach includes:

  • Blocking optimization: Evaluate different blocking agents (BSA, casein, non-fat milk) at various concentrations (1-5%) to identify optimal blocking conditions for your specific sample type.

  • Cross-reactivity assessment: HRP-conjugated antibodies should exhibit minimal cross-reactivity with non-target proteins. Research indicates that high-quality conjugates show less than 2% cross-reactivity with unrelated immunoglobulins .

  • Washing stringency: Implement a gradient of washing stringency to determine optimal conditions:

    • Standard: 3-5 washes with PBS-T (0.05% Tween-20)

    • Intermediate: PBS-T with increased detergent (0.1-0.5% Tween-20)

    • High stringency: High salt wash buffers (up to 500 mM NaCl)

  • Dilution optimization: Excessive antibody concentration increases non-specific binding. Perform serial dilutions to identify the minimum concentration providing acceptable signal-to-noise ratio.

  • Pre-adsorption: Pre-incubate the antibody with non-target tissues or proteins to remove cross-reactive antibodies before use in the primary application.

  • Detection system refinement: Consider switching from colorimetric to chemiluminescent detection for improved signal specificity when background issues persist.

What are the comparative advantages of different chemical conjugation methods for creating OPTC Antibody, HRP conjugates?

Various chemical strategies exist for conjugating HRP to antibodies, each with distinct advantages:

Conjugation MethodMechanismAdvantagesLimitationsOptimal Applications
Periodate methodOxidizes carbohydrates on HRP to create aldehydes that react with antibody aminesPreserves antibody binding capacity, targets glycosylation sites on HRPPotential for heterogeneous conjugationGeneral purpose, widely applicable
Glutaraldehyde methodBifunctional cross-linker reacts with amines on both HRP and antibodySimple procedure, forms stable conjugatesMay affect antibody binding site, potential for polymerizationWhen carbohydrate content of HRP is limited
Maleimide methodTargets sulfhydryl groups on reduced antibodiesHighly specific, controlled conjugation ratioRequires antibody reduction, may alter antibody structureWhen precise control of conjugation site is required
EDC (carbodiimide) methodForms amide bonds between carboxyl and amine groupsWorks with purified proteins, no oxidation requiredPotential for self-polymerizationWhen mild conditions are required

Research demonstrates that the enhanced periodate method incorporating lyophilization offers superior performance over classical methods. This modified approach allows for a higher number of HRP molecules to conjugate to each antibody, creating a poly-HRP effect that significantly improves detection sensitivity .

How can researchers validate the specificity and sensitivity of their OPTC Antibody, HRP conjugated preparations?

A comprehensive validation protocol should include:

  • Spectrophotometric analysis: Confirm successful conjugation through wavelength scanning (280-800 nm). Properly conjugated HRP-antibodies show characteristic absorption patterns with peaks at both 280 nm (antibody) and 430 nm (HRP), with a shift in the 430 nm peak intensity compared to unconjugated HRP .

  • SDS-PAGE verification: Compare migration patterns of conjugated versus unconjugated components. Successful conjugates show altered mobility compared to individual components .

  • Titration analysis: Perform serial dilutions to determine the functional dilution range and compare to unconjugated primary antibody with secondary detection.

  • Cross-reactivity testing: Evaluate specificity against related and unrelated antigens. High-quality conjugates should show minimal cross-reactivity (<2%) with unrelated proteins .

  • Antigen dose-response: Generate standard curves using known antigen concentrations to determine the lower limit of detection. Research demonstrates that enhanced conjugation methods can detect antigens at concentrations as low as 1.5 ng .

  • Comparison with established methods: Benchmark performance against alternative detection systems (e.g., fluorescent conjugates or unconjugated antibody + secondary detection).

  • Application-specific validation: Test in the intended application with appropriate positive and negative controls.

What is the recommended workflow for optimizing OPTC Antibody, HRP conjugated in a new experimental system?

A systematic optimization approach includes:

  • Initial titration: Begin with a broad dilution series (1:100, 1:500, 1:1000, 1:5000) to identify the working range .

  • Fine-tuning: Narrow the dilution range around the best preliminary results (e.g., if 1:1000 works best, test 1:750, 1:1000, 1:1250).

  • Incubation optimization: Test different antibody incubation times and temperatures:

    • Standard: 1-2 hours at room temperature

    • Enhanced sensitivity: Overnight at 4°C

    • Rapid protocol: 30-60 minutes at 37°C

  • Buffer composition testing: Evaluate performance in different buffer systems:

    • PBS-based (pH 7.4) with various detergent concentrations

    • TBS-based (pH 7.5-8.0) for phospho-sensitive applications

    • Specialized buffers for reducing background in specific applications

  • Blocking strategy comparison: Test multiple blocking reagents (BSA, casein, commercial blockers) at different concentrations.

  • Substrate selection: Compare performance with different HRP substrates based on required sensitivity and detection method.

  • Signal-to-noise optimization: Calculate signal-to-noise ratios for each condition to identify the optimal protocol.

Research has shown that HRP-conjugated antibodies produced through enhanced methods can achieve functional detection at dilutions as high as 1:5000, representing significant improvement over traditional methods .

How do sample preparation methods affect the performance of OPTC Antibody, HRP conjugated in different applications?

Sample preparation significantly impacts HRP-conjugated antibody performance:

ApplicationCritical Sample Preparation FactorsRecommended Approaches
Western BlotProtein denaturation conditions, transfer efficiencyUse reducing or non-reducing conditions based on epitope requirements; optimize transfer parameters for target molecular weight
ELISAAntigen coating efficiency, blocking effectivenessTest different coating buffers (carbonate pH 9.6 vs. PBS pH 7.4); evaluate blocking reagents for optimal signal-to-noise ratio
ImmunohistochemistryFixation method, antigen retrieval, endogenous peroxidaseCompare formalin-fixed vs. frozen sections; optimize antigen retrieval methods; block endogenous peroxidase with H₂O₂ treatment
ImmunocytochemistryCell fixation, permeabilization, autofluorescenceTest paraformaldehyde vs. methanol fixation; optimize permeabilization for subcellular targets

Research indicates that sample preparation optimization is essential for maximizing the performance benefits of enhanced HRP-conjugated antibodies, particularly when working with complex biological specimens .

What strategies can improve detection limits when working with low-abundance targets using OPTC Antibody, HRP conjugated?

For detecting low-abundance targets, consider these advanced approaches:

  • Enhanced conjugation methods: Implement the lyophilization-enhanced periodate method to create poly-HRP antibody conjugates with significantly improved sensitivity .

  • Signal amplification systems:

    • Tyramide Signal Amplification (TSA): Can provide 10-200× signal enhancement

    • Polymer-based detection: Multi-enzyme systems attached to dextran polymers

    • Biotinyl tyramide amplification: Combines tyramide chemistry with avidin-biotin systems

  • Substrate optimization: Switch to more sensitive chemiluminescent substrates with longer signal duration for improved detection of weak signals.

  • Sample enrichment: Implement immunoprecipitation or other concentration methods before analysis.

  • Reduce background strategies:

    • Extended blocking (overnight at 4°C)

    • Higher detergent concentrations in wash buffers

    • Extended washing steps (increasing number and duration)

    • Use of specialized blocking reagents for problematic samples

  • Detection instrumentation: Utilize more sensitive detection systems (cooled CCD cameras, photomultiplier-based scanners).

Research demonstrates that enhanced conjugation methods can detect antigens at concentrations as low as 1.5 ng, representing a significant improvement in detection limits .

How can researchers address batch-to-batch variability in OPTC Antibody, HRP conjugated reagents?

Batch variability can significantly impact experimental reproducibility. Implement these strategies to mitigate variability:

  • Standardized characterization protocol:

    • Spectrophotometric analysis to confirm conjugation efficiency through A280/A430 ratios

    • Functional testing against known positive controls at standardized concentrations

    • Titration analysis to establish working dilution ranges

  • Internal reference standards:

    • Maintain aliquots of a well-characterized reference batch

    • Run parallel testing of new and reference batches

    • Establish conversion factors between batches if necessary

  • Quality control checkpoints:

    • Protein concentration verification before conjugation

    • Molar ratio standardization of HRP to antibody

    • Functional testing at multiple dilutions against standard antigens

  • Documentation practices:

    • Maintain detailed records of conjugation conditions

    • Document lot-specific optimal dilutions and performance characteristics

    • Implement antibody validation protocols for each new batch

Research indicates that standardized protocols incorporating lyophilization steps can improve batch-to-batch consistency by controlling critical reaction parameters during conjugation .

What are the molecular mechanisms of signal generation and how do they impact experimental design when using OPTC Antibody, HRP conjugated?

Understanding HRP catalytic mechanisms informs optimal experimental design:

  • Catalytic cycle of HRP:

    • HRP contains a heme group that cycles between resting ferric state, compound I, and compound II during catalysis

    • H₂O₂ oxidizes HRP to form compound I, which then oxidizes substrates in two sequential steps

    • The rate-limiting step can vary depending on substrate and reaction conditions

  • Substrate considerations:

    • Colorimetric substrates (TMB, DAB) offer different sensitivity profiles and kinetic properties

    • Chemiluminescent substrates provide enhanced sensitivity through light emission rather than chromogenic development

  • Impact on experimental design:

    • Substrate concentration affects reaction kinetics - too high causes rapid signal development with high background

    • Reaction timing becomes critical - signal development is time-dependent

    • Signal stability varies by substrate - some provide stable endpoints while others require precise timing

  • Environmental factors:

    • Temperature affects enzyme kinetics (Q10 effect)

    • pH optimum for HRP activity is typically 6.0-6.5

    • Metal ions can either enhance or inhibit HRP activity

By understanding these mechanisms, researchers can optimize reaction conditions for their specific application requirements, balancing sensitivity, specificity, and signal duration .

How do different storage conditions affect the long-term stability of OPTC Antibody, HRP conjugated reagents?

Storage conditions critically impact HRP-conjugated antibody stability:

Storage ConditionTemperatureAdditivesObserved StabilityMechanism of Degradation
Liquid, standard buffer4°CNone1-3 monthsGradual HRP denaturation, microbial growth
Liquid with stabilizers4°C50% glycerol, 1% BSA6-12 monthsReduced protein denaturation, microbial inhibition
Frozen aliquots-20°C50% glycerol1-2 yearsSlowed molecular motion, reduced oxidation
Frozen aliquots-80°CNone2+ yearsMinimal molecular motion
Lyophilized-20°C or 4°CTrehalose or sucrose2+ yearsVitrification, reduced water activity

Research indicates that lyophilized preparation not only enhances conjugation efficiency but also contributes to improved storage stability by reducing water-dependent degradation mechanisms .

To maximize stability:

  • Divide into single-use aliquots to avoid freeze-thaw cycles

  • Add stabilizers appropriate for your application

  • Store protected from light (HRP is photosensitive)

  • Consider lyophilization for very long-term storage needs

How can OPTC Antibody, HRP conjugated be adapted for multiplexed detection systems?

Multiplexed detection with HRP-conjugated antibodies requires strategic approaches:

  • Sequential detection protocols:

    • Utilize different substrates with distinct spectral properties

    • Implement stringent stripping protocols between detection cycles

    • Employ photobleaching to extinguish signals between rounds

  • Spatial separation strategies:

    • Compartmentalized assay designs (microfluidic systems)

    • Bead-based multiplexing with spatial encoding

    • Microarray formats with distinct spatial localization

  • Novel technological adaptations:

    • Tyramide signal amplification with different fluorophores

    • Quantum dot conjugation for spectral multiplexing

    • Coupling with orthogonal enzyme systems (HRP + alkaline phosphatase)

  • Computational approaches:

    • Spectral unmixing algorithms for overlapping signals

    • Machine learning for pattern recognition in complex datasets

    • Statistical methods for deconvolution of multiplexed signals

These approaches enable researchers to detect multiple targets simultaneously while maintaining the sensitivity advantages of HRP-conjugated antibody systems, particularly when enhanced conjugation methods are employed .

What are the emerging technologies that may complement or replace traditional HRP conjugated antibodies?

The immunodetection landscape continues to evolve with several promising technologies:

TechnologyMechanismAdvantagesCurrent LimitationsResearch Status
Nanobody conjugatesSingle-domain antibody fragments with HRPSmaller size, better tissue penetration, reduced backgroundMore limited epitope recognitionEmerging commercial availability
Click chemistry conjugationBio-orthogonal reactions for site-specific labelingPrecise control over conjugation site and stoichiometryRequires antibody modificationActive research area
Poly-HRP systemsPolymeric structures with multiple HRP moleculesDramatic signal amplificationPotential increased backgroundCommercial availability increasing
CRISPR-based detectionCas enzyme systems for nucleic acid detectionExtremely high sensitivity, programmableCurrently limited to nucleic acidsEarly research phase
Digital immunoassaysSingle molecule counting approachesAbsolute quantification, expanded dynamic rangeSpecialized instrumentation requiredGrowing commercial adoption
Electrochemical detectionHRP-generated electroactive productsEquipment simplicity, potential for miniaturizationDifferent optimization parametersWell-established alternative

Despite these advances, enhanced HRP-conjugated antibodies remain a cornerstone technology due to their versatility, established protocols, and continued improvements in conjugation chemistry such as the lyophilization-enhanced method .

Research demonstrates that optimized HRP-conjugation methods continue to provide competitive sensitivity while maintaining the broad applicability that has made these reagents essential in biomedical research .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.